Cafepharma Daily Premium (On-Demand) Archive for September, 2018

Click a link below to view the mailing archive as if it had been sent to you.

2018-09-28 13:42CP Friday Premium: New migraine treatments carry identical price
2018-09-27 23:30CP Thursday Evening Premium: Lilly's migraine approval
2018-09-27 13:13CP Thursday Premium: GW Pharma's Epidiolex heading to launch
2018-09-26 22:30CP Wednesday Evening Premium: Digital therapeutics
2018-09-26 13:05CP Wednesday Premium: Merck CEO Frazier to stay past age 65
2018-09-25 23:16CP Tuesday Evening Premium: Roche's Tecentriq in small cell lung cancer
2018-09-25 12:22CP Tuesday Premium: AstraZeneca's Imfinzi improves NSCLC survival
2018-09-24 23:21CP Monday Evening Premium: AstraZeneca CEO complains about his low pay
2018-09-24 11:50CP Monday Premium: Farixga's 17,000 patient trial success
2018-09-23 22:47CP Sunday Premium
2018-09-22 18:26CP Saturday Premium
2018-09-21 23:38CP Friday Evening Premium
2018-09-21 12:26CP Friday Premium: Should LA be the next big biotech hub?
2018-09-21 00:21CP Thursday Evening Premium: GSK fails to warn of flu vaccine effects
2018-09-20 12:26CP Thursday Premium: Pharma companies using tax havens
2018-09-19 23:47CP Wednesday Evening Premium: Record year for ANDA complete responses
2018-09-19 13:17CP Wednesday Premium: Keytruda in China + Microbiome Report
2018-09-18 22:56CP Tuesday Evening Premium: AbbVie kickback case
2018-09-18 11:15CP Tuesday Premium: Novo Nordisk layoffs
2018-09-17 23:34CP Monday Evening Premium: Senate passes 'pay-for-delay' bill for biosimilars
2018-09-17 13:16CP Monday Premium: AZ vs GSK in COPD
2018-09-16 23:11CP Sunday Premium
2018-09-15 18:33CP Saturday Premium
2018-09-15 00:13CP Friday Evening Premium: Teva migraine med approved
2018-09-14 12:41CP Friday Premium: More cuts for Roche?
2018-09-13 23:47CP Thursday Evening Premium: Sanofi creating new global business units
2018-09-13 23:45CP Thursday Evening Premium: Sanofi creating new global business units
2018-09-13 12:58CP Thursday Premium: Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt
2018-09-12 23:54CP Wednesday Evening Premium: Half of Europe's clinical trials fail to report results
2018-09-12 14:23CP Wednesday Premium: BMS psoriasis success
2018-09-11 23:48CP Tuesday Evening Premium: Takeda laying off 1000 ahead of Shire merger
2018-09-11 12:54CP Tuesday Premium: GSK touts asthma data for Nucala
2018-09-10 23:56CP Monday Evening Premium
2018-09-10 12:53CP Monday Premium: Acadia's new Nuplazid data in dementia-related psychosis
2018-09-10 00:25CP Sunday Premium
2018-09-08 23:52CP Saturday Premium
2018-09-07 19:16CP Friday Evening Premium: GSK ends week with a complete response letter
2018-09-07 12:24CP Friday Premium: Celgene wants to make Revlimid obsolete
2018-09-06 23:30CP Thursday Evening Premium
2018-09-06 13:38CP Thursday Premium: GSK to layoff 650
2018-09-06 00:20CP Wednesday Evening Premium: CAR-T news
2018-09-05 11:33CP Wednesday Premium: Device cybersecurity changes coming, but slowly
2018-09-04 23:42CP Tuesday Evening Premium: Agios' new CEO
2018-09-04 12:38CP Tuesday Premium: Brexit and pharma
2018-09-03 13:17CP Monday Premium
2018-09-01 16:19CP Saturday Premium
2018-09-01 00:04CP Friday Evening Premium

 

<< Archive Index • Subscribe >>

 

Contact Us

Past Issues

Unsubscribe

   
   
   


 

 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語